Skip to main content
HighlightsHighlights Archive

Media Monitoring: 18th-25th February

By February 25, 2022No Comments

New blood tests aim to transform diabetes care

  • A ground-breaking new approach to diabetes treatment is set to be trialled in Tayside following a £2.8m award from the Scottish Government Chief Scientists Office
  • The ‘intelligent Diabetes’ (iDiabetes) project is a joint initiative between NHS Tayside and the University of Dundee, in partnership with the University of Aberdeen and NHS Education Scotland (NES) Digital
  • The project team will develop a new clinical platform which will allow enhanced testing and more sophisticated analysis of patients’ health data

https://www.dundee.ac.uk/stories/new-blood-tests-aim-transform-diabetes-care

 

Decrease in women screened for breast cancer in 2020-21

  • Statistics published by NHS Digital today have found that 1.19m women aged 45 and over were screened for breast cancer in 2020-21, a 44.1% decrease on 2019-20
  • Overall, the number of women aged 45 and over with cancers detected decreased from 17,771 in 2019-20 to 10,813 in 2020-21, a decrease of 39.2%

https://digital.nhs.uk/news/2021/decrease-in-women-screened-for-breast-cancer-in-2020-21

 

NICE draft guidelines recommend wider use of Flash and CGM

  • NICE has published draft guidelines which recommend that Flash glucose monitoring or continuous glucose monitoring should be available for all adults with type 1 diabetes
  • NICE proposals also recommend access to Flash for people with type 2 diabetes who use insulin intensive therapy (4 or more injections a day) and experience regular hypoglycaemia or severe hypoglycaemia, amongst other criteria

https://www.diabetes.org.uk/about_us/news/nice-draft-guidelines-recommend-wider-use-for-flash-and-cgm

 

Point-of-Care diagnostics: a boon awaits under remote healthcare

  • This shift is affecting diagnostics too, particularly when it comes to patients with chronic conditions who need frequent testing
  • For instance, cancer patients may need repeated complete blood count (CBC) tests to see how their condition has progressed and how their body is responding to treatment
  • It has stirred demand for at-home testing solutions, which patients can perform themselves without any risk of catching Covid-19

https://www.medicaldevice-network.com/features/point-of-care-diagnostics-a-boon-awaits-under-remote-healthcare/

 

Prime Minister sets out plan for living with COVID

  • The remaining domestic restrictions in England will be removed. The legal requirement to self-isolate ends. Until 1 April, we still advise people who test positive to stay at home
  • Adults and children who test positive are advised to stay at home and avoid contact with other people for at least five full days and then continue to follow the guidance until they have received two negative test results on consecutive days
  • Fully vaccinated adults and those aged under 18 who are close contacts are no longer advised to test daily for seven days

https://www.gov.uk/government/news/prime-minister-sets-out-plan-for-living-with-covid

 

Washington University School of Medicine develops Alzheimer’s blood test

  • The blood test showed 93% accuracy in identifying people at risk of Alzheimer’s dementia in a study conducted in approximately 500 patients from the US, Australia and Sweden
  • The test evaluates whether accumulation of amyloid plaques has started in the brain based on the ratio of amyloid beta proteins Aβ42 and Aβ40 levels in the blood

https://www.medicaldevice-network.com/news/washington-university-school-of-medicine-blood-test-alzheimers/

 

NHS gene testing does not detect half of people at cancer risk

  • The team at The Institute of Cancer Research, London, found that applying NHS guidelines for gene testing would have excluded many people who had ‘actionable’ genetic alterations that could raise their risk of cancer
  • That means people with an increased risk of developing cancer were missing out on the potential for monitoring, screening or preventive treatment

https://www.icr.ac.uk/news-archive/nhs-gene-testing-does-not-detect-half-of-people-at-cancer-risk

 

Cabinet split over plans to force UK firms to put goods through costly post-Brexit tests

  • Plans to force UK firms to put their goods through costly post-Brexit tests before they can go on sale have been plunged into confusion by a cabinet split

https://www.independent.co.uk/news/uk/politics/brexit-red-tape-jacob-rees-mogg-b2020748.html

Ben Kemp

About Ben Kemp